H.R. 1499 · 116th Congress

Protecting Consumer Access to Generic Drugs Act of 2019

Stage: Reported from committee
Sponsor: Bobby Rush
Introduced: 2019-03-05
Latest action: 2019-05-10 · Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-52, Part I.

Subjects

Administrative law and regulatory procedures

Health

Civil actions and liability

Licensing and registrations

Consumer affairs

Intellectual property

Prescription drugs

Competition and antitrust

Drug safety, medical device, and laboratory regulation

Judicial review and appeals

Federal Trade Commission (FTC)